• Dynasore and the Hidden Logic of Tumor EV Uptake

  2026-10-09

  A translational perspective on how Dynasore can help test whether dynamin-dependent trafficking contributes to Fusobacterium nucleatum extracellular-vesicle biology in colorectal cancer, while preserving clear boundaries between reported evidence, mechanistic hypothesis, and clinical relevance.

• Chlorpromazine: A Framework for Nanomedicine Research

  2026-10-09

  Chlorpromazine is best known for antipsychotic and antiemetic research, but its value also lies in clarifying how pharmacological perturbations should be interpreted alongside nanoparticle biodistribution. This article connects dopamine receptor signaling with the cellular evidence framework reported for PEGylated iron oxide nanoparticles, without treating the two research domains as interchangeable.

• DNase I (RNase-free): Evidence, Uses and Limits

  2026-10-08

  DNase I (RNase-free) is used conceptually for DNA removal in RNA-focused research, including RNA extraction, RT-PCR interpretation, in vitro transcription sample preparation and chromatin studies. This overview separates supplier-described properties from published evidence and explains why the supplied influenza vaccine study does not independently validate any particular DNase I product.

• TUNEL Assay in Renal Amyloidosis Research

  2026-10-08

  A source-grounded overview of how TUNEL-based DNA fragmentation detection can complement mechanistic research on rosemary extract and renal amyloidosis, with emphasis on evidence strength, interpretation limits, and applicability boundaries.

• Nicotine Signaling and Chronic Kidney Disease Progression

  2026-10-07

  Jain and Jaimes integrate clinical observations with animal and mechanistic evidence to explain how nicotine may contribute to chronic kidney disease progression through non-neuronal nicotinic acetylcholine receptors, oxidative stress, and profibrotic signaling. The review’s main contribution is its careful connection of smoking-associated renal outcomes with nicotine biology while recognizing that nicotine is only one component of tobacco smoke and that causality remains incompletely resolved.

• Pollen Interference in Hazardous Aerosol Spectroscopy

  2026-10-07

  A 2024 Molecules study examined how pollen can distort excitation–emission matrix fluorescence classification of hazardous bioaerosol-related samples. By combining spectral transformations with random-forest classification, the authors reported 89.24% accuracy and clearer separation of several bacterial and toxin-related classes, while also identifying important limits for real-world deployment.

• Annexin V-FITC Apoptosis Kit: Interpreting Cell Death

  2026-10-06

  The Annexin V-FITC/PI Apoptosis Assay Kit can do more than classify dying cells: it can anchor a broader evidence framework for interpreting immunogenic cell death. This article connects phosphatidylserine externalization and membrane integrity with findings from recent colorectal cancer research while clarifying what the assay can—and cannot—prove.

• Recombinant Annexin V Purification: Study Insights

  2026-10-06

  Burger and colleagues reported a concise purification strategy for recombinant human annexin V intended for demanding biophysical analyses. The study’s central innovation was combining gentle bacterial-cell opening with calcium-dependent, reversible membrane association and a final ion-exchange separation, yielding protein judged highly pure by gel electrophoresis and HPLC profiling.

• Ro 3306: CDK1 Inhibition in Cell-Cycle Context

  2026-10-05

  Ro 3306 is a selective CDK1 inhibitor used to interpret mitotic entry, G2/M arrest, and DNA repair phenotypes. This article connects CDK1 perturbation with phase-specific mTORC1 signaling to clarify what synchronized-cell results can—and cannot—demonstrate.

• TP53 Mutation, FTH, and Ferroptosis in Glioblastoma

  2026-10-05

  A 2025 Neuroscience Bulletin study links TP53 mutation status to altered iron handling in glioblastoma models through an ITCH–FTH axis. The findings suggest that increased intracellular free iron may create a genotype-associated vulnerability to ferroptosis, although the evidence remains preclinical and requires validation in clinically representative GBM systems.

• DNase I (RNase-Free): Evidence, Scope and Limits

  2026-10-04

  A source-critical overview of DNase I (RNase-free), covering its stated cleavage principles, the meaning of an RNase-free designation, evidence quality, application boundaries, and why the supplied neuroscience study does not validate enzyme performance.

• Shufeng Xingbi Therapy in Allergic Rhinitis Rats

  2026-10-03

  A 2025 bioRxiv preprint examined how Shufeng Xingbi Therapy affects allergic rhinitis in rats through behavioral, nasal-tissue, immune, and gut-microbiota endpoints. The reported improvements are consistent with coordinated changes in allergic inflammation and intestinal metabolites, but the preprint design does not establish clinical efficacy or prove a causal microbiota mechanism.

• DNase I (RNase-free) for Reliable Assays

  2026-10-02

  Learn how DNase I (RNase-free), SKU K1088, can reduce DNA-related confounding in RNA extraction, RT-PCR, and in vitro transcription workflows supporting cell viability, proliferation, and cytotoxicity studies. This scenario-based guide connects enzyme mechanism, protocol controls, transcript-quality interpretation, and practical supplier selection.

• ML133 HCl: An Assay-First Guide to Kir2.1

  2026-10-01

  ML133 HCl is a selective potassium channel inhibitor for dissecting Kir2.1-dependent potassium ion transport. This assay-first guide connects its pH-sensitive pharmacology with pulmonary artery smooth muscle cell proliferation research, experimental controls, and the mechanistic findings of a peer-reviewed pulmonary hypertension study.

• METTL14–DHRS4-AS1 Axis in Ulcerative Colitis

  2026-10-01

  This study identifies METTL14-dependent m6A regulation of the lncRNA DHRS4-AS1 as a protective mechanism in ulcerative colitis. Its cell and mouse experiments connect METTL14 to the DHRS4-AS1/miR-206/A3AR axis, NF-κB activation, apoptosis, and inflammatory tissue injury, offering a mechanistic framework for studying RNA methylation in intestinal inflammation.

8148 records 1/544 page Next 12345 下5页 Last page